The Global Intraoperative Neuromonitoring market accounted for $3.47 billion in 2018 and is expected to reach $7.67 billion by 2027 growing at a CAGR of 9.2% during the forecast period.
Growing prevalence of chronic disorders, rising volume of surgeries and increasing emphasis on patient safety during complicated surgeries are some of the driving factors for the market growth. However, lack of awareness of these applications may restrain the market growth.
Intraoperative neuromonitoring is the use of electrophysiological methods to monitor the functional integrity of certain neural structures during surgery. It detects the key neural structures in the surgical times, and can help reduce and stop impairment and postoperative damage.
Based on Source, Outsourced Monitoring segment is estimated to have a lucrative growth during the forecast period. Outsourced provider can purchase one device and work for many hospitals in the same local area. Outsourcing eliminates the need for hospitals to incur capital expenditure for the purchase of these equipment and bear its maintenance cost.
By geography, Asia Pacific is going to have a lucrative growth due to rising awareness about patient safety during surgery and growing medical tourism in this region.
What the report offers:
Market share assessments for the regional and country level segments
Strategic recommendations for the new entrants
Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis etc.
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements
Key Topics Covered:
1 Executive Summary
2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions
4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry
5 Global Intraoperative Neuromonitoring Market, By Modality 5.1 Introduction 5.2 Electromyography (EMG) 5.3 Sub-Sensory Evoked Potentials 5.4 Motor Evoked Potentials (MEPs) 5.4.1 Visual Evoked Potentials (VEPs) 5.4.2 Brainstem Auditory Evoked Potentials (BAEPs) 5.4.3 Somatosensory Evoked Potentials (SEPs) 5.5 Transcranial Motor Evoked Potentials (TcMEPs) 5.6 Electroencephalography (EEG) 5.7 Mapping of Motor Cortex
6 Global Intraoperative Neuromonitoring Market, By Source 6.1 Introduction 6.2 Insourced Monitoring 6.3 Outsourced Monitoring
7 Global Intraoperative Neuromonitoring Market, By Product & Service 7.1 Introduction 7.2 Systems 7.3 Accessories 7.4 Services
8 Global Intraoperative Neuromonitoring Market, By Application 8.1 Introduction 8.2 Spinal Surgery 8.3 Neurosurgery 8.4 Vascular Surgery 8.5 Ear Nose Throat (ENT) Surgery 8.6 Orthopedic Surgery 8.7 Other Applications
9 Global Intraoperative Neuromonitoring Market, By End User 9.1 Introduction 9.2 Ambulatory Surgical Centers (ASCs) 9.3 Hospitals
10 Global Intraoperative Neuromonitoring Market, By Geography 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.2.3 Mexico 10.3 Europe 10.3.1 Germany 10.3.2 UK 10.3.3 Italy 10.3.4 France 10.3.5 Spain 10.3.6 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Australia 10.4.5 New Zealand 10.4.6 South Korea 10.4.7 Rest of Asia Pacific 10.5 South America 10.5.1 Argentina 10.5.2 Brazil 10.5.3 Chile 10.5.4 Rest of South America 10.6 Middle East & Africa 10.6.1 Saudi Arabia 10.6.2 UAE 10.6.3 Qatar 10.6.4 South Africa 10.6.5 Rest of Middle East & Africa
11 Key Developments 11.1 Agreements, Partnerships, Collaborations and Joint Ventures 11.2 Acquisitions & Mergers 11.3 New Product Launch 11.4 Expansions 11.5 Other Key Strategies
12 Company Profiling 12.1 Medtronic plc 12.2 NuVasive, Inc 12.3 Computational Diagnostics, Inc 12.4 SpecialtyCare 12.5 Natus Medical Incorporated 12.6 IntraNerve, LLC 12.7 inomed Medizintechnik GmbH 12.8 Accurate Monitoring LLC 12.9 Nihon Kohden Corporation 12.10 Moberg Research, Inc 12.11 Bromedicon 12.12 NuVasive 12.13 American Intraoperative Monitoring 12.14 Bovie Medical 12.15 Checkpoint Surgical